Submitted:
29 July 2026
Posted:
30 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction


2. Spongiform Degeneration in Transmissible Spongiform Encephalopathies (TSEs)
2.1. White Matter Involvement in TSEs
2.2. Roles of Normal Cellular Prion Protein (PrPC) in Myelination
2.3. Integrated Perspective
3. Lipid Homeostasis and Lysosomal Storage Diseases
3.1. Myelin Lipids
3.2. Canavan Disease and N-Acetylaspartate Metabolism
3.3. PNPLA6 and Phospholipid Homeostasis
3.4. FIG4, VAC14, and PI(3,5)P2 Signaling Link Lipid Homeostasis to Lysosomal Storage Defects
3.5. PI(3,5)P2 and Mucolipidosis Type IV
3.6. Broader Spectrum of Lysosomal and Autophagic Disorders
3.7. Mechanistic Insights
4. Mitochondrial Dysfunction and Spongiform Change
4.1. Mitochondrial Disorders
4.2. Mouse Mutants with Mitochondrial Dysfunction
4.3. Mechanistic Insights
5. Potassium Homeostasis
5.1. Potassium Buffering and Kir4.1 Channels
5.2. The Role of Glial Gap Junctions in Potassium Homeostasis
5.3. Mechanistic Insights
6. Direct Connections Between Spongiosis and Myelin Proteins
6.1. Proteolipid Protein 1 (PLP1)
6.2. Transcriptional Regulation of Myelination

6.3. Mechanistic Insights
7. Conclusions

Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| CNS | Central nervous system |
| PNS | Peripheral nervous system |
| TSE | Transmissible spongiform encephalopathy |
| CJD | Creutzfeldt-Jakob disease |
| PrPSc | Prion protein, scrapie form |
| PrPC | Prion protein, normal cellular form |
| Prnp | Mouse prion protein gene |
| ADGRG6 | Adhesion G-protein coupled receptor 6 |
| cAMP | Cyclic adenosine monophosphate |
| PKA | Protein kinase A |
| Egr2 | Early growth response 2 gene |
| MBP | Myelin basic protein |
| MPZ | Myelin protein zero |
| PMP22 | Peripheral myelin protein 22 |
| Fe3+ | Ferric iron |
| Fe2+ | Ferrous iron |
| ER | Endoplasmic reticulum |
| LSD | Lysosomal storage disease |
| GalC | Galactolipid galactocerbroside |
| UGT8 | UDP-galactose:ceramide galactosyltransferase |
| UDP | Uridine diphosphate |
| 4-AP | 4-aminopyridine |
| GAL3ST1 | Galactose-3-O-sulfotransferase 1 |
| CST | Cerebroside sulfotransferase |
| Cers2 | Ceramide synthase 2 gene |
| ASPA | Aspartoacylase gene |
| ASPA | Aspartoacylase (protein) |
| NAA | N-acetyl-L-aspartate |
| PNPLA6 | Patatin-like phospholipase domain-containing protein |
| NTE | Neuropathy target esterase |
| LPC | Lysophosphatidylcholine |
| LPE | Lysophosphatidylethanolamine |
| Kir | Inward rectifying potassium channels |
| K+ | Potassium ion(s) |
| sws | Swiss-Cheese gene (Drosophila) |
| ROS | Reactive oxygen species |
| SPG39 | Hereditary spastic paraplegia type 39 |
| Fig4/FIG4 | Factor-induced gene 4 (mouse/human) |
| FIG4 | Factor-induced gene 4 protein |
| VAC14 | Vac14 homolog (S. cerevisiae) protein |
| PIKFYVE | Phosphoinositide kinase, FYVE-type zinc finger containing |
| FAB1 | PIKFYVE in mammals |
| PI(3,5)P2 | Phosphatidylinositol 3,5-bisphosphate |
| LAMP1 | Lysosome-associated membrane protein 1 |
| RAB7 | RAB7, member RAS oncogene family |
| MAG | Myelin associated glycoprotein |
| PLP1 | Proteolipid protein |
| CMT4J | Charcot-Marie-Tooth disease, type 4J |
| MLIV | Mucolipidosis type IV |
| MCOLN1 | Mucolipin-1 gene |
| TRPML1 | Transient receptor potential mucolipin 1 |
| TMEM106B | Transmembrane protein 106B |
| ESCRT | Endosomal sorting complex required for transport |
| Tsg101 | Tumor susceptibility gene 101 (mouse) |
| TSG101 | Tumor susceptibility gene 101 protein |
| NCOA4 | Nuclear receptor coactivator 4 |
| NDUFS4 | NADH:ubiquinone oxidoreductase subunit S4 |
| NADH | Nicotinamide adenine dinucleotide |
| TLE | Toxic spongiform leukoencephalopathy |
| Sod2 | Superoxide dismutase 2 gene (mouse) |
| SOD2 | Superoxide dismutase 2 protein |
| Nfe2l2 | Nuclear factor, erythroid derived 2, like 2 gene (mouse) |
| Nrf2 | Alternate name for Nfe2l2 |
| PGC-1a | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| NRF1 | Nuclear respiratory factor 1 |
| ATP | Adenosine triphosphate |
| MGRN1 | Mahogunin, ring finger 1 |
| ATRN | Attractin |
| Mgrn1 | Mahogunin, ring finger 1 gene (mouse) |
| DMT1 | Divalent metal transporter 1 |
| SLC11A2 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
| Kir4.1 | inwardly rectifying potassium channel encoded by the KCNJ10 gene |
| KCNJ10 | potassium inwardly-rectifying channel, subfamily J, member 10 gene (human) |
| Kcnj10 | potassium inwardly-rectifying channel, subfamily J, member 10 gene (mouse) |
| EAST | Epilepsy, Ataxia, Sensorineural deafness, and Tubulopathy |
| SeSAME | Seizures, Sensorineural deafness, Ataxia, Mental retardation, and Electrolyte imbalance (alternate name for EAST syndrome) |
| Cx | Connexin |
| GJC2 | Gap junction protein, gamma 2 gene (human), encodes Cx47 |
| PMLD1 | Pelizaeus-Merzbacher-like disease 1 |
| GJB1 | Gap junction protein, beta 1 gene (human), encodes Cx32 |
| CMT1X | Charcot-Marie-Tooth disease, type 1X |
| Gjc2 | Gap junction protein, gamma 2 gene (mouse) |
| Gjb1 | Gap junction protein, beta 1 gene (mouse) |
| CNP | 2':3'-cyclic nucleotide-3'-phosphodiesterase |
| PMD | Pelizaeus-Merzbacher disease |
| SPG2 | Spastic paraplegia type 2 |
| DM20 | Diphasic myelin transcript (alternatively spliced isoform of PLP1) |
| SOX10 | SRY (sex determining region Y)-box 10 |
| PCWH | Peripheral demyelinating neuropathy, Central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease |
| gt | gray tremor (mouse Sox10 mutant allele) |
| SOXE | SRY (sex determining region Y)-box family E |
| Cldn11 | Claudin-11 gene (mouse) |
| Myrf | Myelin regulatory factor gene (mouse) |
| MYRF | Myelin regulatory factor protein |
| HLD22 | Hypomyelinating leukodystrophy |
| MMERV | MYRF-related mild encephalopathy with reversible myelin vacuolization |
References
- Silvius, D.; Pitstick, R.; Ahn, M.; Meishery, D.; Oehler, A.; Barsh, G.S.; DeArmond, S.J.; Carlson, G.A.; Gunn, T.M. Levels of the Mahogunin Ring Finger 1 E3 Ubiquitin Ligase Do Not Influence Prion Disease. PLOS ONE 2013, 8, e55575. [CrossRef]
- Simons, M.; Nave, K.-A. Oligodendrocytes: Myelination and Axonal Support. Cold Spring Harb. Perspect. Biol. 2015, 8, a020479. [CrossRef]
- Rasband, M.N.; Macklin, W.B. Chapter 10 - Myelin Structure and Biochemistry. In Basic Neurochemistry (Eighth Edition); Brady, S.T., Siegel, G.J., Albers, R.W., Price, D.L., Eds.; Academic Press: New York, 2012; pp. 180–199 ISBN 978-0-12-374947-5.
- Moore, R.A.; Taubner, L.M.; Priola, S.A. Prion Protein Misfolding and Disease. Curr. Opin. Struct. Biol. 2009, 19, 14–22. [CrossRef]
- Prusiner, S.B. Novel Proteinaceous Infectious Particles Cause Scrapie. Science 1982, 216, 136–144. [CrossRef]
- Hadlow, W.J. Reflections on the Transmissible Spongiform Encephalopathies. Vet. Pathol. 1999, 36, 523–529. [CrossRef]
- Liberski, P.P. Spongiform Change--an Electron Microscopic View. Folia Neuropathol. 2004, 42 Suppl B, 59–70.
- Caverzasi, E.; Mandelli, M.L.; DeArmond, S.J.; Hess, C.P.; Vitali, P.; Papinutto, N.; Oehler, A.; Miller, B.L.; Lobach, I.V.; Bastianello, S.; et al. White Matter Involvement in Sporadic Creutzfeldt-Jakob Disease. Brain 2014, 137, 3339–3354. [CrossRef]
- Matsusue, E.; Kinoshita, T.; Sugihara, S.; Fujii, S.; Ogawa, T.; Ohama, E. White Matter Lesions in Panencephalopathic Type of Creutzfeldt-Jakob Disease: MR Imaging and Pathologic Correlations. AJNR Am. J. Neuroradiol. 2004, 25, 910–918.
- Reiniger, L.; Mirabile, I.; Lukic, A.; Wadsworth, J.D.; Linehan, J.M.; Groves, M.; Lowe, J.; Druyeh, R.; Rudge, P.; Collinge, J.; et al. Filamentous White Matter Prion Protein Deposition Is a Distinctive Feature of Multiple Inherited Prion Diseases. Acta Neuropathol. Commun. 2013, 1, 8. [CrossRef]
- Sasaki, S.; Mizoi, S.; Akashima, A.; Shinagawa, M.; Goto, H. Spongiform Encephalopathy in Sheep Scrapie : Electron Microscopic Observations. Jpn. J. Vet. Sci. 1986, 48, 791–796. [CrossRef]
- Liberski, P.P.; Yanagihara, R.; Wells, G.A.H.; Gibbs, C.J.; Gajdusek, D.C. Ultrastructural Pathology of Axons and Myelin in Experimental Scrapie in Hamsters and Bovine Spongiform Encephalopathy in Cattle and a Comparison with the Panencephalopathic Type of Creutzfeldt-Jakob Disease. J. Comp. Pathol. 1992, 106, 383–398. [CrossRef]
- Liu, X.-L.; Feng, X.-L.; Wang, G.-M.; Gong, B.-B.; Ahmad, W.; Liu, N.-N.; Zhang, Y.-Y.; Yang, L.; Ren, H.-L.; Cui, S.-S. Exploration of the Main Sites for the Transformation of Normal Prion Protein (PrPC) into Pathogenic Prion Protein (PrPsc). J. Vet. Res. 2017, 61, 11–22. [CrossRef]
- Reiniger, L.; Mirabile, I.; Lukic, A.; Wadsworth, J.D.; Linehan, J.M.; Groves, M.; Lowe, J.; Druyeh, R.; Rudge, P.; Collinge, J.; et al. Filamentous White Matter Prion Protein Deposition Is a Distinctive Feature of Multiple Inherited Prion Diseases. Acta Neuropathol. Commun. 2013, 1, 8. [CrossRef]
- Prinz, M.; Montrasio, F.; Furukawa, H.; Haar, M.E. van der; Schwarz, P.; Rülicke, T.; Giger, O.T.; Häusler, K.-G.; Perez, D.; Glatzel, M.; et al. Intrinsic Resistance of Oligodendrocytes to Prion Infection. J. Neurosci. 2004, 24, 5974–5981. [CrossRef]
- Moser, M.; Colello, R.J.; Pott, U.; Oesch, B. Developmental Expression of the Prion Protein Gene in Glial Cells. Neuron 1995, 14, 509–517. [CrossRef]
- Nazor, K.E.; Seward, T.; Telling, G.C. Motor Behavioral and Neuropathological Deficits in Mice Deficient for Normal Prion Protein Expression. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 2007, 1772, 645–653. [CrossRef]
- Bremer, J.; Baumann, F.; Tiberi, C.; Wessig, C.; Fischer, H.; Schwarz, P.; Steele, A.D.; Toyka, K.V.; Nave, K.-A.; Weis, J.; et al. Axonal Prion Protein Is Required for Peripheral Myelin Maintenance. Nat. Neurosci. 2010, 13, 310–318. [CrossRef]
- Zhu, C.; Li, B.; Yu, G.; Chen, J.; Yu, H.; Chen, J.; Xu, X.; Wu, Y.; Zhang, A.; Cheng, G. Production of Prnp-/- Goats by Gene Targeting in Adult Fibroblasts. Transgenic Res. 2009, 18, 163–171. [CrossRef]
- Richt, J.A.; Kasinathan, P.; Hamir, A.N.; Castilla, J.; Sathiyaseelan, T.; Vargas, F.; Sathiyaseelan, J.; Wu, H.; Matsushita, H.; Koster, J.; et al. Production of Cattle Lacking Prion Protein. Nat. Biotechnol. 2007, 25, 132–138. [CrossRef]
- Skedsmo, F.S.; Malachin, G.; Våge, D.I.; Hammervold, M.M.; Salvesen, Ø.; Ersdal, C.; Ranheim, B.; Stafsnes, M.H.; Bartosova, Z.; Bruheim, P.; et al. Demyelinating Polyneuropathy in Goats Lacking Prion Protein. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2020, 34, 2359–2375. [CrossRef]
- Nuvolone, M.; Hermann, M.; Sorce, S.; Russo, G.; Tiberi, C.; Schwarz, P.; Minikel, E.; Sanoudou, D.; Pelczar, P.; Aguzzi, A. Strictly Co-Isogenic C57BL/6J-Prnp−/− Mice: A Rigorous Resource for Prion Science. J. Exp. Med. 2016, 213, 313–327. [CrossRef]
- Küffer, A.; Lakkaraju, A.K.K.; Mogha, A.; Petersen, S.C.; Airich, K.; Doucerain, C.; Marpakwar, R.; Bakirci, P.; Senatore, A.; Monnard, A.; et al. The Prion Protein Is an Agonistic Ligand of the G Protein-Coupled Receptor Adgrg6. Nature 2016, 536, 464–468. [CrossRef]
- Mogha, A.; Benesh, A.E.; Patra, C.; Engel, F.B.; Schöneberg, T.; Liebscher, I.; Monk, K.R. Gpr126 Functions in Schwann Cells to Control Differentiation and Myelination via G-Protein Activation. J. Neurosci. 2013, 33, 17976–17985. [CrossRef]
- Glenn, T.D.; Talbot, W.S. Analysis of Gpr126 Function Defines Distinct Mechanisms Controlling the Initiation and Maturation of Myelin. Development 2013, 140, 3167–3175. [CrossRef]
- Brown, D.R.; Qin, K.; Herms, J.W.; Madlung, A.; Manson, J.; Strome, R.; Fraser, P.E.; Kruck, T.; von Bohlen, A.; Schulz-Schaeffer, W.; et al. The Cellular Prion Protein Binds Copper in Vivo. Nature 1997, 390, 684–687. [CrossRef]
- MILLHAUSER, G.L. Copper Binding in the Prion Protein. Acc. Chem. Res. 2004, 37, 79–85. [CrossRef]
- Singh, A.; Haldar, S.; Horback, K.; Tom, C.; Zhou, L.; Meyerson, H.; Singh, N. Prion Protein Regulates Iron Transport by Functioning as a Ferrireductase. J. Alzheimers Dis. JAD 2013, 35, 541–552. [CrossRef]
- Connor, J.R.; Menzies, S.L. Relationship of Iron to Oligodendrocytes and Myelination. Glia 1996, 17, 83–93. [CrossRef]
- Cheli, V.T.; Correale, J.; Paez, P.M.; Pasquini, J.M. Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination. ASN Neuro 2020, 12, 1759091420962681. [CrossRef]
- Singh, A.; Mohan, M.L.; Isaac, A.O.; Luo, X.; Petrak, J.; Vyoral, D.; Singh, N. Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis. PloS One 2009, 4, e4468. [CrossRef]
- Gasperini, L.; Meneghetti, E.; Legname, G.; Benetti, F. In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution. Front. Neurosci. 2016, 10. [CrossRef]
- Yang, D.; Wang, X.; Zhang, L.; Fang, Y.; Zheng, Q.; Liu, X.; Yu, W.; Chen, S.; Ying, J.; Hua, F. Lipid Metabolism and Storage in Neuroglia: Role in Brain Development and Neurodegenerative Diseases. Cell Biosci. 2022, 12, 106. [CrossRef]
- Lipids as Emerging Biomarkers in Neurodegenerative Diseases Available online: https://www.mdpi.com/1422-0067/25/1/131 (accessed on 19 June 2026).
- Duncan, G.J.; Simkins, T.J.; Emery, B. Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons. Front. Cell Dev. Biol. 2021, 9. [CrossRef]
- Marshall-Phelps, K.L.H.; Almeida, R.G. Axonal Neurotransmitter Release in the Regulation of Myelination. Biosci. Rep. 2024, 44, BSR20231616. [CrossRef]
- Brown, M.S.; Goldstein, J.L. Familial Hypercholesterolemia: Defective Binding of Lipoproteins to Cultured Fibroblasts Associated with Impaired Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity. Proc. Natl. Acad. Sci. U. S. A. 1974, 71, 788–792. [CrossRef]
- Singh, R.; Kaushik, S.; Wang, Y.; Xiang, Y.; Novak, I.; Komatsu, M.; Tanaka, K.; Cuervo, A.M.; Czaja, M.J. Autophagy Regulates Lipid Metabolism. Nature 2009, 458, 1131–1135. [CrossRef]
- Ebner, M.; Fröhlich, F.; Haucke, V. Mechanisms and Functions of Lysosomal Lipid Homeostasis. Cell Chem. Biol. 2025, 32, 392–407. [CrossRef]
- Bosio, A.; Büssow, H.; Adam, J.; Stoffel, W. Galactosphingolipids and Axono-Glial Interaction in Myelin of the Central Nervous System. Cell Tissue Res. 1998, 292, 199–210. [CrossRef]
- Coetzee, T.; Fujita, N.; Dupree, J.; Shi, R.; Blight, A.; Suzuki, K.; Suzuki, K.; Popko, B. Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability. Cell 1996, 86, 209–219. [CrossRef]
- Marcus, J.; Dupree, J.L.; Popko, B. Myelin-Associated Glycoprotein and Myelin Galactolipids Stabilize Developing Axo-Glial Interactions. J. Cell Biol. 2002, 156, 567–577. [CrossRef]
- Dupree, J.L.; Coetzee, T.; Blight, A.; Suzuki, K.; Popko, B. Myelin Galactolipids Are Essential for Proper Node of Ranvier Formation in the CNS. J. Neurosci. 1998, 18, 1642–1649. [CrossRef]
- Honke, K.; Hirahara, Y.; Dupree, J.; Suzuki, K.; Popko, B.; Fukushima, K.; Fukushima, J.; Nagasawa, T.; Yoshida, N.; Wada, Y.; et al. Paranodal Junction Formation and Spermatogenesis Require Sulfoglycolipids. Proc. Natl. Acad. Sci. 2002, 99, 4227–4232. [CrossRef]
- Sun, H.; Mo, L.; Cao, M.; Tian, Y.; Mo, L.; Ni, Z.; Zhang, S.; Huang, X.; Wang, Y.; Lam, S.M.; et al. Very Long Chain Sphingolipids Govern Brain Myelination by Regulating Oligodendrocyte Differentiation and Membrane Microdomain Integrity. J. Transl. Med. 2026, 24, 550. [CrossRef]
- Ben-David, O.; Pewzner-Jung, Y.; Brenner, O.; Laviad, E.L.; Kogot-Levin, A.; Weissberg, I.; Biton, I.E.; Pienik, R.; Wang, E.; Kelly, S.; et al. Encephalopathy Caused by Ablation of Very Long Acyl Chain Ceramide Synthesis May Be Largely Due to Reduced Galactosylceramide Levels. J. Biol. Chem. 2011, 286, 30022–30033. [CrossRef]
- Baslow, M.H. Canavan’s Spongiform Leukodystrophy: A Clinical Anatomy of a Genetic Metabolic CNS Disease. J. Mol. Neurosci. MN 2000, 15, 61–69. [CrossRef]
- Kirmani, B.F.; Jacobowitz, D.M.; Namboodiri, M. a. A. Developmental Increase of Aspartoacylase in Oligodendrocytes Parallels CNS Myelination. Brain Res. Dev. Brain Res. 2003, 140, 105–115. [CrossRef]
- Baslow, M.H.; Suckow, R.F.; Sapirstein, V.; Hungund, B.L. Expression of Aspartoacylase Activity in Cultured Rat Macroglial Cells Is Limited to Oligodendrocytes. J. Mol. Neurosci. MN 1999, 13, 47–53. [CrossRef]
- Madhavarao, C.N.; Moffett, J.R.; Moore, R.A.; Viola, R.E.; Namboodiri, M.A.A.; Jacobowitz, D.M. Immunohistochemical Localization of Aspartoacylase in the Rat Central Nervous System. J. Comp. Neurol. 2004, 472, 318–329. [CrossRef]
- Matalon, R.; Michals, K.; Sebesta, D.; Deanching, M.; Gashkoff, P.; Casanova, J. Aspartoacylase Deficiency and N-Acetylaspartic Aciduria in Patients with Canavan Disease. Am. J. Med. Genet. 1988, 29, 463–471. [CrossRef]
- Surendran, S.; Campbell, G.A.; Tyring, S.K.; Matalon, R. Aspartoacylase Gene Knockout Results in Severe Vacuolation in the White Matter and Gray Matter of the Spinal Cord in the Mouse. Neurobiol. Dis. 2005, 18, 385–389. [CrossRef]
- Traka, M.; Wollmann, R.L.; Cerda, S.R.; Dugas, J.; Barres, B.A.; Popko, B. Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28, 11537–11549. [CrossRef]
- Chakraborty, G.; Mekala, P.; Yahya, D.; Wu, G.; Ledeen, R.W. Intraneuronal N-Acetylaspartate Supplies Acetyl Groups for Myelin Lipid Synthesis: Evidence for Myelin-Associated Aspartoacylase. J. Neurochem. 2001, 78, 736–745. [CrossRef]
- Mehta, V.; Namboodiri, M.A. N-Acetylaspartate as an Acetyl Source in the Nervous System. Brain Res. Mol. Brain Res. 1995, 31, 151–157. [CrossRef]
- Baslow, M.H.; Guilfoyle, D.N. Canavan Disease, a Rare Early-Onset Human Spongiform Leukodystrophy: Insights into Its Genesis and Possible Clinical Interventions. Biochimie 2013, 95, 946–956. [CrossRef]
- Hoshino, H.; Kubota, M. Canavan Disease: Clinical Features and Recent Advances in Research. Pediatr. Int. Off. J. Jpn. Pediatr. Soc. 2014, 56, 477–483. [CrossRef]
- Madhavarao, C.N.; Arun, P.; Moffett, J.R.; Szucs, S.; Surendran, S.; Matalon, R.; Garbern, J.; Hristova, D.; Johnson, A.; Jiang, W.; et al. Defective N-Acetylaspartate Catabolism Reduces Brain Acetate Levels and Myelin Lipid Synthesis in Canavan’s Disease. Proc. Natl. Acad. Sci. 2005, 102, 5221–5226. [CrossRef]
- Wei, H.; Moffett, J.R.; Amanat, M.; Fatemi, A.; Tsukamoto, T.; Namboodiri, A.M.; Slusher, B.S. The Pathogenesis of, and Pharmacological Treatment for, Canavan Disease. Drug Discov. Today 2022, 27, 2467–2483. [CrossRef]
- Francis, J.S.; Strande, L.; Markov, V.; Leone, P. Aspartoacylase Supports Oxidative Energy Metabolism during Myelination. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2012, 32, 1725–1736. [CrossRef]
- Singhal, N.K.; Huang, H.; Li, S.; Clements, R.; Gadd, J.; Daniels, A.; Kooijman, E.E.; Bannerman, P.; Burns, T.; Guo, F.; et al. The Neuronal Metabolite NAA Regulates Histone H3 Methylation in Oligodendrocytes and Myelin Lipid Composition. Exp. Brain Res. 2017, 235, 279–292. [CrossRef]
- Kretzschmar, D. PNPLA6/NTE, an Evolutionary Conserved Phospholipase Linked to a Group of Complex Human Diseases. Metabolites 2022, 12, 284. [CrossRef]
- Li, Y.; Dinsdale, D.; Glynn, P. Protein Domains, Catalytic Activity, and Subcellular Distribution of Neuropathy Target Esterase in Mammalian Cells. J. Biol. Chem. 2003, 278, 8820–8825. [CrossRef]
- Quistad, G.B.; Barlow, C.; Winrow, C.J.; Sparks, S.E.; Casida, J.E. Evidence That Mouse Brain Neuropathy Target Esterase Is a Lysophospholipase. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 7983–7987. [CrossRef]
- Zaccheo, O.; Dinsdale, D.; Meacock, P.A.; Glynn, P. Neuropathy Target Esterase and Its Yeast Homologue Degrade Phosphatidylcholine to Glycerophosphocholine in Living Cells. J. Biol. Chem. 2004, 279, 24024–24033. [CrossRef]
- Plemel, J.R.; Michaels, N.J.; Weishaupt, N.; Caprariello, A.V.; Keough, M.B.; Rogers, J.A.; Yukseloglu, A.; Lim, J.; Patel, V.V.; Rawji, K.S.; et al. Mechanisms of Lysophosphatidylcholine-Induced Demyelination: A Primary Lipid Disrupting Myelinopathy. Glia 2018, 66, 327–347. [CrossRef]
- Akassoglou, K.; Malester, B.; Xu, J.; Tessarollo, L.; Rosenbluth, J.; Chao, M.V. Brain-Specific Deletion of Neuropathy Target Esterase/Swisscheese Results in Neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 5075–5080. [CrossRef]
- Rosenbluth, J.; Schiff, R.; Lam, P.; Nuriel, T.; Chao, M.V. Spongiform Pathology in Mouse CNS Lacking ‘Neuropathy Target Esterase’ and Cellular Prion Protein. Neurobiol. Dis. 2009, 35, 433–437. [CrossRef]
- Read, D.J.; Li, Y.; Chao, M.V.; Cavanagh, J.B.; Glynn, P. Neuropathy Target Esterase Is Required for Adult Vertebrate Axon Maintenance. J. Neurosci. 2009, 29, 11594–11600. [CrossRef]
- Ryabova, E.V.; Melentev, P.A.; Komissarov, A.E.; Surina, N.V.; Ivanova, E.A.; Matiytsiv, N.; Shcherbata, H.R.; Sarantseva, S.V. Morpho-Functional Consequences of Swiss Cheese Knockdown in Glia of Drosophila Melanogaster. Cells 2021, 10, 529. [CrossRef]
- Melentev, P.A.; Ryabova, E.V.; Surina, N.V.; Zhmujdina, D.R.; Komissarov, A.E.; Ivanova, E.A.; Boltneva, N.P.; Makhaeva, G.F.; Sliusarenko, M.I.; Yatsenko, A.S.; et al. Loss of Swiss Cheese in Neurons Contributes to Neurodegeneration with Mitochondria Abnormalities, Reactive Oxygen Species Acceleration and Accumulation of Lipid Droplets in Drosophila Brain. Int. J. Mol. Sci. 2021, 22, 8275. [CrossRef]
- Dutta, S.; Rieche, F.; Eckl, N.; Duch, C.; Kretzschmar, D. Glial Expression of Swiss Cheese (SWS), the Drosophila Orthologue of Neuropathy Target Esterase (NTE), Is Required for Neuronal Ensheathment and Function. Dis. Model. Mech. 2016, 9, 283–294. [CrossRef]
- Tsap, M.I.; Yatsenko, A.S.; Hegermann, J.; Beckmann, B.; Tsikas, D.; Shcherbata, H.R. Unraveling the Link between Neuropathy Target Esterase NTE/SWS, Lysosomal Storage Diseases, Inflammation, Abnormal Fatty Acid Metabolism, and Leaky Brain Barrier. eLife 2024, 13, e98020. [CrossRef]
- Mühlig-Versen, M.; da Cruz, A.B.; Tschäpe, J.-A.; Moser, M.; Büttner, R.; Athenstaedt, K.; Glynn, P.; Kretzschmar, D. Loss of Swiss Cheese/Neuropathy Target Esterase Activity Causes Disruption of Phosphatidylcholine Homeostasis and Neuronal and Glial Death in Adult Drosophila. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25, 2865–2873. [CrossRef]
- Botelho, R.J.; Efe, J.A.; Teis, D.; Emr, S.D. Assembly of a Fab1 Phosphoinositide Kinase Signaling Complex Requires the Fig4 Phosphoinositide Phosphatase. Mol. Biol. Cell 2008, 19, 4273–4286. [CrossRef]
- Jin, N.; Chow, C.Y.; Liu, L.; Zolov, S.N.; Bronson, R.; Davisson, M.; Petersen, J.L.; Zhang, Y.; Park, S.; Duex, J.E.; et al. VAC14 Nucleates a Protein Complex Essential for the Acute Interconversion of PI3P and PI(3,5)P(2) in Yeast and Mouse. EMBO J. 2008, 27, 3221–3234. [CrossRef]
- Zolov, S.N.; Bridges, D.; Zhang, Y.; Lee, W.-W.; Riehle, E.; Verma, R.; Lenk, G.M.; Converso-Baran, K.; Weide, T.; Albin, R.L.; et al. In Vivo, Pikfyve Generates PI(3,5)P2, Which Serves as Both a Signaling Lipid and the Major Precursor for PI5P. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 17472–17477. [CrossRef]
- Lenk, G.M.; Meisler, M.H. Mouse Models of PI(3,5)P2 Deficiency with Impaired Lysosome Function. Methods Enzymol. 2014, 534, 245–260. [CrossRef]
- Mironova, Y.A.; Lenk, G.M.; Lin, J.-P.; Lee, S.J.; Twiss, J.L.; Vaccari, I.; Bolino, A.; Havton, L.A.; Min, S.H.; Abrams, C.S.; et al. PI(3,5)P2 Biosynthesis Regulates Oligodendrocyte Differentiation by Intrinsic and Extrinsic Mechanisms. eLife 2016, 5, e13023. [CrossRef]
- Chow, C.Y.; Zhang, Y.; Dowling, J.J.; Jin, N.; Adamska, M.; Shiga, K.; Szigeti, K.; Shy, M.E.; Li, J.; Zhang, X.; et al. Mutation of FIG4 Causes Neurodegeneration in the Pale Tremor Mouse and Patients with CMT4J. Nature 2007, 448, 68–72. [CrossRef]
- Ferguson, C.J.; Lenk, G.M.; Jones, J.M.; Grant, A.E.; Winters, J.J.; Dowling, J.J.; Giger, R.J.; Meisler, M.H. Neuronal Expression of Fig4 Is Both Necessary and Sufficient to Prevent Spongiform Neurodegeneration. Hum. Mol. Genet. 2012, 21, 3525–3534. [CrossRef]
- Simons, M.; Trajkovic, K. Neuron-Glia Communication in the Control of Oligodendrocyte Function and Myelin Biogenesis. J. Cell Sci. 2006, 119, 4381–4389. [CrossRef]
- Simons, M.; Trajkovic, K. Neuron-Glia Communication in the Control of Oligodendrocyte Function and Myelin Biogenesis. J. Cell Sci. 2006, 119, 4381–4389. [CrossRef]
- Winterstein, C.; Trotter, J.; Krämer-Albers, E.-M. Distinct Endocytic Recycling of Myelin Proteins Promotes Oligodendroglial Membrane Remodeling. J. Cell Sci. 2008, 121, 834–842. [CrossRef]
- Bassi, M.T.; Manzoni, M.; Monti, E.; Pizzo, M.T.; Ballabio, A.; Borsani, G. Cloning of the Gene Encoding a Novel Integral Membrane Protein, Mucolipidin-and Identification of the Two Major Founder Mutations Causing Mucolipidosis Type IV. Am. J. Hum. Genet. 2000, 67, 1110–1120. [CrossRef]
- Bargal, R.; Avidan, N.; Ben-Asher, E.; Olender, Z.; Zeigler, M.; Frumkin, A.; Raas-Rothschild, A.; Glusman, G.; Lancet, D.; Bach, G. Identification of the Gene Causing Mucolipidosis Type IV. Nat. Genet. 2000, 26, 118–123. [CrossRef]
- Raychowdhury, M.K.; González-Perrett, S.; Montalbetti, N.; Timpanaro, G.A.; Chasan, B.; Goldmann, W.H.; Stahl, S.; Cooney, A.; Goldin, E.; Cantiello, H.F. Molecular Pathophysiology of Mucolipidosis Type IV: pH Dysregulation of the Mucolipin-1 Cation Channel. Hum. Mol. Genet. 2004, 13, 617–627. [CrossRef]
- Rue, B.E.; Dischler, A.M.; Salvagio, L.A.; Zhu, M.; Xu, G.; Flores, P.C.; Donovan, C.L.; Liu, X.; Minckley, T.F.; Agulnek, B.; et al. Differential Ion Selectivity and Disease-Associated Dysfunction of TRPML Channels Revealed by Patient and Engineered Mutants. J. Biol. Chem. 2026, 302, 110953. [CrossRef]
- Colletti, G.A.; Kiselyov, K. TRPML1. Adv. Exp. Med. Biol. 2011, 704, 209–219. [CrossRef]
- Di Paola, S.; Scotto-Rosato, A.; Medina, D.L. TRPML1: The Ca(2+)Retaker of the Lysosome. Cell Calcium 2018, 69, 112–121. [CrossRef]
- Dong, X.-P.; Cheng, X.; Mills, E.; Delling, M.; Wang, F.; Kurz, T.; Xu, H. The Type IV Mucolipidosis-Associated Protein TRPML1 Is an Endolysosomal Iron Release Channel. Nature 2008, 455, 992–996. [CrossRef]
- Wang, W.; Zhang, X.; Gao, Q.; Xu, H. TRPML1: An Ion Channel in the Lysosome. Handb. Exp. Pharmacol. 2014, 222, 631–645. [CrossRef]
- Dong, X.; Shen, D.; Wang, X.; Dawson, T.; Li, X.; Zhang, Q.; Cheng, X.; Zhang, Y.; Weisman, L.S.; Delling, M.; et al. PI(3,5)P(2) Controls Membrane Trafficking by Direct Activation of Mucolipin Ca(2+) Release Channels in the Endolysosome. Nat. Commun. 2010, 1, 38. [CrossRef]
- Li, X.; Wang, X.; Zhang, X.; Zhao, M.; Tsang, W.L.; Zhang, Y.; Yau, R.G.W.; Weisman, L.S.; Xu, H. Genetically Encoded Fluorescent Probe to Visualize Intracellular Phosphatidylinositol 3,5-Bisphosphate Localization and Dynamics. Proc. Natl. Acad. Sci. 2013, 110, 21165–21170. [CrossRef]
- Dong, X.-P.; Wang, X.; Xu, H. TRP Channels of Intracellular Membranes. J. Neurochem. 2010, 113, 313–328. [CrossRef]
- Cao, Q.; Yang, Y.; Zhong, X.Z.; Dong, X.-P. The Lysosomal Ca2+ Release Channel TRPML1 Regulates Lysosome Size by Activating Calmodulin. J. Biol. Chem. 2017, 292, 8424–8435. [CrossRef]
- Wenger, D.A.; Rafi, M.A.; Luzi, P.; Datto, J.; Costantino-Ceccarini, E. Krabbe Disease: Genetic Aspects and Progress toward Therapy. Mol. Genet. Metab. 2000, 70, 1–9. [CrossRef]
- Feng, T.; Sheng, R.R.; Solé-Domènech, S.; Ullah, M.; Zhou, X.; Mendoza, C.S.; Enriquez, L.C.M.; Katz, I.I.; Paushter, D.H.; Sullivan, P.M.; et al. A Role of the Frontotemporal Lobar Degeneration Risk Factor TMEM106B in Myelination. Brain 2020, 143, 2255–2271. [CrossRef]
- Walker, W.P.; Oehler, A.; Edinger, A.L.; Wagner, K.-U.; Gunn, T.M. Oligodendroglial Deletion of ESCRT-I Component TSG101 Causes Spongiform Encephalopathy. Biol. Cell 2016, 108, 324–337. [CrossRef]
- Bache, K.G.; Brech, A.; Mehlum, A.; Stenmark, H. Hrs Regulates Multivesicular Body Formation via ESCRT Recruitment to Endosomes. J. Cell Biol. 2003, 162, 435–442. [CrossRef]
- Kaur, J.; Debnath, J. Autophagy at the Crossroads of Catabolism and Anabolism. Nat. Rev. Mol. Cell Biol. 2015, 16, 461–472. [CrossRef]
- Ruhoy, I.S.; Saneto, R.P. The Genetics of Leigh Syndrome and Its Implications for Clinical Practice and Risk Management. Appl. Clin. Genet. 2014, 7, 221–234. [CrossRef]
- Magro, G.; Laterza, V.; Tosto, F. Leigh Syndrome: A Comprehensive Review of the Disease and Present and Future Treatments. Biomedicines 2025, 13, 733. [CrossRef]
- van de Wal, M.A.E.; Adjobo-Hermans, M.J.W.; Keijer, J.; Schirris, T.J.J.; Homberg, J.R.; Wieckowski, M.R.; Grefte, S.; van Schothorst, E.M.; van Karnebeek, C.; Quintana, A.; et al. Ndufs4 Knockout Mouse Models of Leigh Syndrome: Pathophysiology and Intervention. Brain J. Neurol. 2022, 145, 45–63. [CrossRef]
- Quintana, A.; Kruse, S.E.; Kapur, R.P.; Sanz, E.; Palmiter, R.D. Complex I Deficiency Due to Loss of Ndufs4 in the Brain Results in Progressive Encephalopathy Resembling Leigh Syndrome. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 10996–11001. [CrossRef]
- Maisenbacher, M.; Arcot Jayagopal, L. Chasing the New Dragon. Neurology 2026, 106, e214517. [CrossRef]
- Wolters, E.C.; van Wijngaarden, G.K.; Stam, F.C.; Rengelink, H.; Lousberg, R.J.; Schipper, M.E.; Verbeeten, B. Leucoencephalopathy after Inhaling “Heroin” Pyrolysate. Lancet 1982, 2, 1233–1237. [CrossRef]
- Alshamam, M.S.; Sumbly, V.; Nso, N.; Saliaj, M.; Gurung, D.O. Heroin-Induced Leukoencephalopathy. Cureus 13, e13093. [CrossRef]
- Melov, S.; Schneider, J.A.; Day, B.J.; Hinerfeld, D.; Coskun, P.; Mirra, S.S.; Crapo, J.D.; Wallace, D.C. A Novel Neurological Phenotype in Mice Lacking Mitochondrial Manganese Superoxide Dismutase. Nat. Genet. 1998, 18, 159–163. [CrossRef]
- Hubbs, A.F.; Benkovic, S.A.; Miller, D.B.; O’Callaghan, J.P.; Battelli, L.; Schwegler-Berry, D.; Ma, Q. Vacuolar Leukoencephalopathy with Widespread Astrogliosis in Mice Lacking Transcription Factor Nrf2. Am. J. Pathol. 2007, 170, 2068–2076. [CrossRef]
- Weisiger, R.A.; Fridovich, I. Superoxide Dismutase. Organelle Specificity. J. Biol. Chem. 1973, 248, 3582–3592.
- He, F.; Ru, X.; Wen, T. NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci. 2020, 21, 4777. [CrossRef]
- Bronson, R.T.; Donahue, L.R.; Samples, R.; Kim, J.H.; Naggert, J.K. Mice with Mutations in the Mahogany Gene Atrn Have Cerebral Spongiform Changes. J. Neuropathol. Exp. Neurol. 2001, 60, 724–730. [CrossRef]
- He, L.; Lu, X.-Y.; Jolly, A.F.; Eldridge, A.G.; Watson, S.J.; Jackson, P.K.; Barsh, G.S.; Gunn, T.M. Spongiform Degeneration in Mahoganoid Mutant Mice. Science 2003, 299, 710–712. [CrossRef]
- He, L.; Gunn, T.M.; Bouley, D.M.; Lu, X.Y.; Watson, S.J.; Schlossman, S.F.; Duke-Cohan, J.S.; Barsh, G.S. A Biochemical Function for Attractin in Agouti-Induced Pigmentation and Obesity. Nat. Genet. 2001, 27, 40–47. [CrossRef]
- Gunn, T.M.; Silvius, D.; Lester, A.; Gibbs, B. Chronic and Age-Dependent Effects of the Spongiform Neurodegeneration-Associated MGRN1 E3 Ubiquitin Ligase on Mitochondrial Homeostasis. Mamm. Genome Off. J. Int. Mamm. Genome Soc. 2019, 30, 151–165. [CrossRef]
- Sun, K.; Johnson, B.S.; Gunn, T.M. Mitochondrial Dysfunction Precedes Neurodegeneration in Mahogunin (Mgrn1) Mutant Mice. Neurobiol. Aging 2007, 28, 1840–1852. [CrossRef]
- Parashara, P.; Gao, L.; Riglos, A.; Lartey, D.; Sidhu, S.B.; Marks, T.; Williams, C.; Siauw, G.; Lee, K.-J.; Ostrem, A.I.L.; et al. The E3 Ubiquitin Ligase MGRN1 Targets Melanocortin Receptors MC1R and MC4R via Interactions with Transmembrane Adapters. J. Cell Sci. 2025, 138, jcs264084. [CrossRef]
- Mukherjee, R.; Chakrabarti, O. Regulation of Mitofusin1 by Mahogunin Ring Finger-1 and the Proteasome Modulates Mitochondrial Fusion. Biochim. Biophys. Acta 2016, 1863, 3065–3083. [CrossRef]
- Ben Zichri- David, S.; Shkuri, L.; Ast, T. Pulling Back the Mitochondria’s Iron Curtain. Npj Metab. Health Dis. 2025, 3, 6. [CrossRef]
- Stehling, O.; Wilbrecht, C.; Lill, R. Mitochondrial Iron-Sulfur Protein Biogenesis and Human Disease. Biochimie 2014, 100, 61–77. [CrossRef]
- Koleini, N.; Shapiro, J.S.; Geier, J.; Ardehali, H. Ironing out Mechanisms of Iron Homeostasis and Disorders of Iron Deficiency. J. Clin. Invest. 131, e148671. [CrossRef]
- Valsecchi, F.; Grefte, S.; Roestenberg, P.; Joosten-Wagenaars, J.; Smeitink, J.A.M.; Willems, P.H.G.M.; Koopman, W.J.H. Primary Fibroblasts of NDUFS4(-/-) Mice Display Increased ROS Levels and Aberrant Mitochondrial Morphology. Mitochondrion 2013, 13, 436–443. [CrossRef]
- Kalsi, A.S.; Greenwood, K.; Wilkin, G.; Butt, A.M. Kir4.1 Expression by Astrocytes and Oligodendrocytes in CNS White Matter: A Developmental Study in the Rat Optic Nerve. J. Anat. 2004, 204, 475–485. [CrossRef]
- Schirmer, L.; Möbius, W.; Zhao, C.; Cruz-Herranz, A.; Ben Haim, L.; Cordano, C.; Shiow, L.R.; Kelley, K.W.; Sadowski, B.; Timmons, G.; et al. Oligodendrocyte-Encoded Kir4.1 Function Is Required for Axonal Integrity. eLife 2018, 7, e36428. [CrossRef]
- Looser, Z.J.; Faik, Z.; Ravotto, L.; Zanker, H.S.; Jung, R.B.; Werner, H.B.; Ruhwedel, T.; Möbius, W.; Bergles, D.E.; Barros, L.F.; et al. Oligodendrocyte-Axon Metabolic Coupling Is Mediated by Extracellular K+ and Maintains Axonal Health. Nat. Neurosci. 2024, 27, 433–448. [CrossRef]
- Brasko, C.; Hawkins, V.; De La Rocha, I.C.; Butt, A.M. Expression of Kir4.1 and Kir5.1 Inwardly Rectifying Potassium Channels in Oligodendrocytes, the Myelinating Cells of the CNS. Brain Struct. Funct. 2017, 222, 41–59. [CrossRef]
- Zhang, Y.; Chen, K.; Sloan, S.A.; Bennett, M.L.; Scholze, A.R.; O’Keeffe, S.; Phatnani, H.P.; Guarnieri, P.; Caneda, C.; Ruderisch, N.; et al. An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. J. Neurosci. Off. J. Soc. Neurosci. 2014, 34, 11929–11947. [CrossRef]
- Bockenhauer, D.; Feather, S.; Stanescu, H.C.; Bandulik, S.; Zdebik, A.A.; Reichold, M.; Tobin, J.; Lieberer, E.; Sterner, C.; Landoure, G.; et al. Epilepsy, Ataxia, Sensorineural Deafness, Tubulopathy, and KCNJ10 Mutations. N. Engl. J. Med. 2009, 360, 1960–1970. [CrossRef]
- Scholl, U.I.; Choi, M.; Liu, T.; Ramaekers, V.T.; Häusler, M.G.; Grimmer, J.; Tobe, S.W.; Farhi, A.; Nelson-Williams, C.; Lifton, R.P. Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, and Electrolyte Imbalance (SeSAME Syndrome) Caused by Mutations in KCNJ10. Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 5842–5847. [CrossRef]
- Neusch, C.; Rozengurt, N.; Jacobs, R.E.; Lester, H.A.; Kofuji, P. Kir4.1 Potassium Channel Subunit Is Crucial for Oligodendrocyte Development and in Vivo Myelination. J. Neurosci. Off. J. Soc. Neurosci. 2001, 21, 5429–5438. [CrossRef]
- Goodenough, D.A.; Paul, D.L. Gap Junctions. Cold Spring Harb. Perspect. Biol. 2009, 1, a002576. [CrossRef]
- Orthmann-Murphy, J.L.; Freidin, M.; Fischer, E.; Scherer, S.S.; Abrams, C.K. Two Distinct Heterotypic Channels Mediate Gap Junction Coupling between Astrocyte and Oligodendrocyte Connexins. J. Neurosci. Off. J. Soc. Neurosci. 2007, 27, 13949–13957. [CrossRef]
- Nagy, J.I.; Rash, J.E. Connexins and Gap Junctions of Astrocytes and Oligodendrocytes in the CNS. Brain Res. Brain Res. Rev. 2000, 32, 29–44. [CrossRef]
- Kamasawa, N.; Sik, A.; Morita, M.; Yasumura, T.; Davidson, K.G.V.; Nagy, J.I.; Rash, J.E. Connexin-47 and Connexin-32 in Gap Junctions of Oligodendrocyte Somata, Myelin Sheaths, Paranodal Loops and Schmidt-Lanterman Incisures: Implications for Ionic Homeostasis and Potassium Siphoning. Neuroscience 2005, 136, 65–86. [CrossRef]
- Magnotti, L.M.; Goodenough, D.A.; Paul, D.L. Functional Heterotypic Interactions between Astrocyte and Oligodendrocyte Connexins. Glia 2011, 59, 26–34. [CrossRef]
- Abrams, C.K.; Scherer, S.S. Gap Junctions in Inherited Human Disorders of the Central Nervous System. Biochim. Biophys. Acta 2012, 1818, 2030–2047. [CrossRef]
- Abrams, C.K. Mechanisms of Diseases Associated with Mutation in GJC2/Connexin 47. Biomolecules 2023, 13, 712. [CrossRef]
- Kim, M.S.; Gloor, G.B.; Bai, D. The Distribution and Functional Properties of Pelizaeus-Merzbacher-like Disease-Linked Cx47 Mutations on Cx47/Cx47 Homotypic and Cx47/Cx43 Heterotypic Gap Junctions. Biochem. J. 2013, 452, 249–258. [CrossRef]
- Uhlenberg, B.; Schuelke, M.; Rüschendorf, F.; Ruf, N.; Kaindl, A.M.; Henneke, M.; Thiele, H.; Stoltenburg-Didinger, G.; Aksu, F.; Topaloğlu, H.; et al. Mutations in the Gene Encoding Gap Junction Protein Alpha 12 (Connexin 46.6) Cause Pelizaeus-Merzbacher-like Disease. Am. J. Hum. Genet. 2004, 75, 251–260. [CrossRef]
- Bugiani, M.; Al Shahwan, S.; Lamantea, E.; Bizzi, A.; Bakhsh, E.; Moroni, I.; Balestrini, M.R.; Uziel, G.; Zeviani, M. GJA12 Mutations in Children with Recessive Hypomyelinating Leukoencephalopathy. Neurology 2006, 67, 273–279. [CrossRef]
- Orthmann-Murphy, J.L.; Enriquez, A.D.; Abrams, C.K.; Scherer, S.S. Loss-of-Function GJA12/Connexin47 Mutations Cause Pelizaeus-Merzbacher-like Disease. Mol. Cell. Neurosci. 2007, 34, 629–641. [CrossRef]
- Bergoffen, J.; Trofatter, J.; Pericak-Vance, M.A.; Haines, J.L.; Chance, P.F.; Fischbeck, K.H. Linkage Localization of X-Linked Charcot-Marie-Tooth Disease. Am. J. Hum. Genet. 1993, 52, 312–318.
- Scherer, S.S.; Kleopa, K.A. X-Linked Charcot-Marie-Tooth Disease. J. Peripher. Nerv. Syst. JPNS 2012, 17 Suppl 3, 9–13. [CrossRef]
- Menichella, D.M.; Goodenough, D.A.; Sirkowski, E.; Scherer, S.S.; Paul, D.L. Connexins Are Critical for Normal Myelination in the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23, 5963–5973. [CrossRef]
- Odermatt, B.; Wellershaus, K.; Wallraff, A.; Seifert, G.; Degen, J.; Euwens, C.; Fuss, B.; Büssow, H.; Schilling, K.; Steinhäuser, C.; et al. Connexin 47 (Cx47)-Deficient Mice with Enhanced Green Fluorescent Protein Reporter Gene Reveal Predominant Oligodendrocytic Expression of Cx47 and Display Vacuolized Myelin in the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2003, 23, 4549–4559. [CrossRef]
- Sutor, B.; Schmolke, C.; Teubner, B.; Schirmer, C.; Willecke, K. Myelination Defects and Neuronal Hyperexcitability in the Neocortex of Connexin 32-Deficient Mice. Cereb. Cortex 2000, 10, 684–697. [CrossRef]
- Sargiannidou, I.; Vavlitou, N.; Aristodemou, S.; Hadjisavvas, A.; Kyriacou, K.; Scherer, S.S.; Kleopa, K.A. Connexin32 Mutations Cause Loss of Function in Schwann Cells and Oligodendrocytes Leading to PNS and CNS Myelination Defects. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29, 4736–4749. [CrossRef]
- Scherer, S.S.; Xu, Y.T.; Nelles, E.; Fischbeck, K.; Willecke, K.; Bone, L.J. Connexin32-Null Mice Develop Demyelinating Peripheral Neuropathy. Glia 1998, 24, 8–20. [CrossRef]
- Anzini, P.; Neuberg, D.H.; Schachner, M.; Nelles, E.; Willecke, K.; Zielasek, J.; Toyka, K.V.; Suter, U.; Martini, R. Structural Abnormalities and Deficient Maintenance of Peripheral Nerve Myelin in Mice Lacking the Gap Junction Protein Connexin 32. J. Neurosci. Off. J. Soc. Neurosci. 1997, 17, 4545–4551. [CrossRef]
- Menichella, D.M.; Majdan, M.; Awatramani, R.; Goodenough, D.A.; Sirkowski, E.; Scherer, S.S.; Paul, D.L. Genetic and Physiological Evidence That Oligodendrocyte Gap Junctions Contribute to Spatial Buffering of Potassium Released during Neuronal Activity. J. Neurosci. 2006, 26, 10984–10991. [CrossRef]
- Magnotti, L.M.; Goodenough, D.A.; Paul, D.L. Deletion of Oligodendrocyte Cx32 and Astrocyte Cx43 Causes White Matter Vacuolation, Astrocyte Loss and Early Mortality. Glia 2011, 59, 1064–1074. [CrossRef]
- Tress, O.; Maglione, M.; May, D.; Pivneva, T.; Richter, N.; Seyfarth, J.; Binder, S.; Zlomuzica, A.; Seifert, G.; Theis, M.; et al. Panglial Gap Junctional Communication Is Essential for Maintenance of Myelin in the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32, 7499–7518. [CrossRef]
- Lutz, S.E.; Zhao, Y.; Gulinello, M.; Lee, S.C.; Raine, C.S.; Brosnan, C.F. Deletion of Astrocyte Connexins 43 and 30 Leads to a Dysmyelinating Phenotype and Hippocampal CA1 Vacuolation. J. Neurosci. Off. J. Soc. Neurosci. 2009, 29, 7743–7752. [CrossRef]
- Rash, J.E. Molecular Disruptions of the Panglial Syncytium Block Potassium Siphoning and Axonal Saltatory Conduction: Pertinence to Neuromyelitis Optica and Other Demyelinating Diseases of the Central Nervous System. Neuroscience 2010, 168, 982–1008. [CrossRef]
- Morell, P.; Quarles, R.H. Characteristic Composition of Myelin. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition; Lippincott-Raven, 1999.
- Khalaf, G.; Mattern, C.; Begou, M.; Boespflug-Tanguy, O.; Massaad, C.; Massaad-Massade, L. Mutation of Proteolipid Protein 1 Gene: From Severe Hypomyelinating Leukodystrophy to Inherited Spastic Paraplegia. Biomedicines 2022, 10, 1709. [CrossRef]
- Gencic, S.; Abuelo, D.; Ambler, M.; Hudson, L.D. Pelizaeus-Merzbacher Disease: An X-Linked Neurologic Disorder of Myelin Metabolism with a Novel Mutation in the Gene Encoding Proteolipid Protein. Am. J. Hum. Genet. 1989, 45, 435–442.
- Hudson, L.D.; Puckett, C.; Berndt, J.; Chan, J.; Gencic, S. Mutation of the Proteolipid Protein Gene PLP in a Human X Chromosome-Linked Myelin Disorder. Proc. Natl. Acad. Sci. U. S. A. 1989, 86, 8128–8131. [CrossRef]
- Laukka, J.J.; Kamholz, J.; Bessert, D.; Skoff, R.P. Novel Pathologic Findings in Patients with Pelizaeus-Merzbacher Disease. Neurosci. Lett. 2016, 627, 222–232. [CrossRef]
- Greer, J.M.; Lees, M.B. Myelin Proteolipid Protein--the First 50 Years. Int. J. Biochem. Cell Biol. 2002, 34, 211–215. [CrossRef]
- Nave, K.A.; Lai, C.; Bloom, F.E.; Milner, R.J. Splice Site Selection in the Proteolipid Protein (PLP) Gene Transcript and Primary Structure of the DM-20 Protein of Central Nervous System Myelin. Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 5665–5669. [CrossRef]
- Appikatla, S.; Bessert, D.; Lee, I.; Hüttemann, M.; Mullins, C.; Somayajulu-Nitu, M.; Yao, F.; Skoff, R.P. Insertion of Proteolipid Protein into Oligodendrocyte Mitochondria Regulates Extracellular pH and Adenosine Triphosphate. Glia 2014, 62, 356–373. [CrossRef]
- Hüttemann, M.; Zhang, Z.; Mullins, C.; Bessert, D.; Lee, I.; Nave, K.-A.; Appikatla, S.; Skoff, R.P. Different Proteolipid Protein Mutants Exhibit Unique Metabolic Defects. ASN Neuro 2009, 1, e00014. [CrossRef]
- Somayajulu, M.; Bessert, D.A.; Hüttemann, M.; Sohi, J.; Kamholz, J.; Skoff, R.P. Insertion of Proteolipid Protein into Mitochondria but Not DM20 Regulates Metabolism of Cells. Neurosci. Lett. 2018, 678, 90–98. [CrossRef]
- Duan, R.; Li, L.; Yan, H.; He, M.; Gao, K.; Xing, S.; Ji, H.; Wang, J.; Cao, B.; Li, D.; et al. Novel Insight into the Potential Pathogenicity of Mitochondrial Dysfunction Resulting from PLP1 Duplication Mutations in Patients with Pelizaeus–Merzbacher Disease. Neuroscience 2021, 476, 60–71. [CrossRef]
- Numata, Y.; Morimura, T.; Nakamura, S.; Hirano, E.; Kure, S.; Goto, Y.-I.; Inoue, K. Depletion of Molecular Chaperones from the Endoplasmic Reticulum and Fragmentation of the Golgi Apparatus Associated with Pathogenesis in Pelizaeus-Merzbacher Disease. J. Biol. Chem. 2013, 288, 7451–7466. [CrossRef]
- Ruiz, M.; Bégou, M.; Launay, N.; Ranea-Robles, P.; Bianchi, P.; López-Erauskin, J.; Morató, L.; Guilera, C.; Petit, B.; Vaurs-Barriere, C.; et al. Oxidative Stress and Mitochondrial Dynamics Malfunction Are Linked in Pelizaeus-Merzbacher Disease. Brain Pathol. 2018, 28, 611–630. [CrossRef]
- Numasawa-Kuroiwa, Y.; Okada, Y.; Shibata, S.; Kishi, N.; Akamatsu, W.; Shoji, M.; Nakanishi, A.; Oyama, M.; Osaka, H.; Inoue, K.; et al. Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes. Stem Cell Rep. 2014, 2, 648–661. [CrossRef]
- Southwood, C.M.; Garbern, J.; Jiang, W.; Gow, A. The Unfolded Protein Response Modulates Disease Severity in Pelizaeus-Merzbacher Disease. Neuron 2002, 36, 585–596. [CrossRef]
- Gow, A.; Southwood, C.M.; Lazzarini, R.A. Disrupted Proteolipid Protein Trafficking Results in Oligodendrocyte Apoptosis in an Animal Model of Pelizaeus-Merzbacher Disease. J. Cell Biol. 1998, 140, 925–934. [CrossRef]
- Inoue, K.; Khajavi, M.; Ohyama, T.; Hirabayashi, S.; Wilson, J.; Reggin, J.D.; Mancias, P.; Butler, I.J.; Wilkinson, M.F.; Wegner, M.; et al. Molecular Mechanism for Distinct Neurological Phenotypes Conveyed by Allelic Truncating Mutations. Nat. Genet. 2004, 36, 361–369. [CrossRef]
- Verheij, J.B.G.M.; Sival, D.A.; van der Hoeven, J.H.; Vos, Y.J.; Meiners, L.C.; Brouwer, O.F.; van Essen, A.J. Shah-Waardenburg Syndrome and PCWH Associated with SOX10 Mutations: A Case Report and Review of the Literature. Eur. J. Paediatr. Neurol. EJPN Off. J. Eur. Paediatr. Neurol. Soc. 2006, 10, 11–17. [CrossRef]
- Akutsu, Y.; Shirai, K.; Takei, A.; Goto, Y.; Aoyama, T.; Watanabe, A.; Imamura, M.; Enokizono, T.; Ohto, T.; Hori, T.; et al. A Patient with Peripheral Demyelinating Neuropathy, Central Dysmyelinating Leukodystrophy, Waardenburg Syndrome, and Severe Hypoganglionosis Associated with a Novel SOX10 Mutation. Am. J. Med. Genet. A. 2018, 176, 1195–1199. [CrossRef]
- Inoue, K.; Tanabe, Y.; Lupski, J.R. Myelin Deficiencies in Both the Central and the Peripheral Nervous Systems Associated with a SOX10 Mutation. Ann. Neurol. 1999, 46, 313–318. [CrossRef]
- Anderson, S.R.; Lee, I.; Ebeling, C.; Stephenson, D.A.; Schweitzer, K.M.; Baxter, D.; Moon, T.M.; LaPierre, S.; Jaques, B.; Silvius, D.; et al. Disrupted SOX10 Function Causes Spongiform Neurodegeneration in Gray Tremor Mice. Mamm. Genome Off. J. Int. Mamm. Genome Soc. 2015, 26, 80–93. [CrossRef]
- Carlson, G.A.; Banks, S.; Lund, D.; Reichert, C.; Groth, D.; Torchia, M.; Dearmond, S.J.; Prusiner, S.B. Failure to Transmit Disease from Gray Tremor Mutant Mice. J. Virol. 1997, 71, 2342–2345. [CrossRef]
- Peirano, R.I.; Wegner, M. The Glial Transcription Factor Sox10 Binds to DNA Both as Monomer and Dimer with Different Functional Consequences. Nucleic Acids Res. 2000, 28, 3047–3055. [CrossRef]
- Schlierf, B.; Ludwig, A.; Klenovsek, K.; Wegner, M. Cooperative Binding of Sox10 to DNA: Requirements and Consequences. Nucleic Acids Res. 2002, 30, 5509–5516. [CrossRef]
- Huang, Y.-H.; Jankowski, A.; Cheah, K.S.E.; Prabhakar, S.; Jauch, R. SOXE Transcription Factors Form Selective Dimers on Non-Compact DNA Motifs through Multifaceted Interactions between Dimerization and High-Mobility Group Domains. Sci. Rep. 2015, 5, 10398. [CrossRef]
- Gotoh, L.; Inoue, K.; Helman, G.; Mora, S.; Maski, K.; Soul, J.S.; Bloom, M.; Evans, S.H.; Goto, Y.-I.; Caldovic, L.; et al. GJC2 Promoter Mutations Causing Pelizaeus-Merzbacher-like Disease. Mol. Genet. Metab. 2014, 111, 393–398. [CrossRef]
- Meyer, E.; Kurian, M.A.; Morgan, N.V.; McNeill, A.; Pasha, S.; Tee, L.; Younis, R.; Norman, A.; van der Knaap, M.S.; Wassmer, E.; et al. Promoter Mutation Is a Common Variant in GJC2-Associated Pelizaeus-Merzbacher-like Disease. Mol. Genet. Metab. 2011, 104, 637–643. [CrossRef]
- Osaka, H.; Hamanoue, H.; Yamamoto, R.; Nezu, A.; Sasaki, M.; Saitsu, H.; Kurosawa, K.; Shimbo, H.; Matsumoto, N.; Inoue, K. Disrupted SOX10 Regulation of GJC2 Transcription Causes Pelizaeus-Merzbacher-like Disease. Ann. Neurol. 2010, 68, 250–254. [CrossRef]
- Devaux, J.; Gow, A. Tight Junctions Potentiate the Insulative Properties of Small CNS Myelinated Axons. J. Cell Biol. 2008, 183, 909–921. [CrossRef]
- Gow, A.; Southwood, C.M.; Li, J.S.; Pariali, M.; Riordan, G.P.; Brodie, S.E.; Danias, J.; Bronstein, J.M.; Kachar, B.; Lazzarini, R.A. CNS Myelin and Sertoli Cell Tight Junction Strands Are Absent in Osp/Claudin-11 Null Mice. Cell 1999, 99, 649–659. [CrossRef]
- Denninger, A.R.; Breglio, A.; Maheras, K.J.; LeDuc, G.; Cristiglio, V.; Demé, B.; Gow, A.; Kirschner, D.A. Claudin-11 Tight Junctions in Myelin Are a Barrier to Diffusion and Lack Strong Adhesive Properties. Biophys. J. 2015, 109, 1387–1397. [CrossRef]
- Riedhammer, K.M.; Stockler, S.; Ploski, R.; Wenzel, M.; Adis-Dutschmann, B.; Ahting, U.; Alhaddad, B.; Blaschek, A.; Haack, T.B.; Kopajtich, R.; et al. De Novo Stop-Loss Variants in CLDN11 Cause Hypomyelinating Leukodystrophy. Brain J. Neurol. 2021, 144, 411–419. [CrossRef]
- Bujalka, H.; Koenning, M.; Jackson, S.; Perreau, V.M.; Pope, B.; Hay, C.M.; Mitew, S.; Hill, A.F.; Lu, Q.R.; Wegner, M.; et al. MYRF Is a Membrane-Associated Transcription Factor That Autoproteolytically Cleaves to Directly Activate Myelin Genes. PLoS Biol. 2013, 11, e1001625. [CrossRef]
- Hornig, J.; Fröb, F.; Vogl, M.R.; Hermans-Borgmeyer, I.; Tamm, E.R.; Wegner, M. The Transcription Factors Sox10 and Myrf Define an Essential Regulatory Network Module in Differentiating Oligodendrocytes. PLoS Genet. 2013, 9, e1003907. [CrossRef]
- Aprato, J.; Sock, E.; Weider, M.; Elsesser, O.; Fröb, F.; Wegner, M. Myrf Guides Target Gene Selection of Transcription Factor Sox10 during Oligodendroglial Development. Nucleic Acids Res. 2020, 48, 1254–1270. [CrossRef]
- Emery, B.; Agalliu, D.; Cahoy, J.D.; Watkins, T.A.; Dugas, J.C.; Mulinyawe, S.B.; Ibrahim, A.; Ligon, K.L.; Rowitch, D.H.; Barres, B.A. Myelin Gene Regulatory Factor Is a Critical Transcriptional Regulator Required for CNS Myelination. Cell 2009, 138, 172–185. [CrossRef]
- Koenning, M.; Jackson, S.; Hay, C.M.; Faux, C.; Kilpatrick, T.J.; Willingham, M.; Emery, B. Myelin Gene Regulatory Factor Is Required for Maintenance of Myelin and Mature Oligodendrocyte Identity in the Adult CNS. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32, 12528–12542. [CrossRef]
- Kurahashi, H.; Azuma, Y.; Masuda, A.; Okuno, T.; Nakahara, E.; Imamura, T.; Saitoh, M.; Mizuguchi, M.; Shimizu, T.; Ohno, K.; et al. MYRF Is Associated with Encephalopathy with Reversible Myelin Vacuolization. Ann. Neurol. 2018, 83, 98–106. [CrossRef]
- Yao, S.; Mo, X.; Luo, C.; Qu, C. MYRF-Related Mild Encephalopathy with Reversible Myelin Vacuolization: A Case Report and Literature Review. Front. Genet. 2023, 14, 1284060. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).